Qingdao Baheal Medical INC. (SHE:301015)
China · Delayed Price · Currency is CNY 25.86
-0.34 (-1.30%)
Aug 21, 2026, 3:04 PM CST
SHE:301015 Market Cap
SHE:301015 has a market cap or net worth of 13.59 billion as of August 21, 2026. Its market cap has increased by 1.57% in one year.
Market Cap
13.59B
Enterprise Value
14.97B
Revenue
7.45B
Ranking
n/a
PE Ratio
26.95
Stock Price
25.86
ChartMarket Cap Chart
Since June 30, 2021, SHE:301015's market cap has decreased from 29.49B to 13.59B, a decrease of -53.91%. That is a compound annual growth rate of -13.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 13.59B | 9.58% |
| Dec 31, 2025 | 12.40B | -2.52% |
| Dec 31, 2024 | 12.73B | -32.42% |
| Dec 29, 2023 | 18.83B | 50.42% |
| Dec 30, 2022 | 12.52B | -21.32% |
| Dec 31, 2021 | 15.91B | -46.05% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 54.76B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 32.46B |
| Jointown Pharmaceutical Group | 24.68B |
| China National Medicines Corporation | 20.48B |
| Liaoning Cheng Da | 15.95B |
| China Meheco Group | 14.00B |
| China National Accord Medicines Corporation | 11.43B |
| C.Q. Pharmaceutical Holding | 9.69B |